Friday, May 1, 2026

Yuhan’s Leclaza and J&J’s Rybrevant: How This Cancer Combo Surged Past 1 Billion USD in Sales

Sales of Yuhan's lung cancer drug 'Lazertinib' and J&J's 'Amivantamab' exceeded 1 trillion won last year.

Yoon Suk Yeol Speaks Out: ‘The Rule of Law Has Completely Broken Down’

President Yoon Suk Yeol complies with a controversial investigation, condemning illegal actions by law enforcement in South Korea.

Boycott Hits Tesla Globally, But China Remains an Unlikely Sanctuary

A global Tesla boycott grows, but China supports Musk. Sales drop in Germany and Canada, while Musk remains popular in China.

Tag: feasibility

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.